An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

Completed · Not applicable

Conditions studied: Gastroesophageal Reflux Disease

In brief

Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)

Key facts

Study ID

NCT01058070

Run by

Torax Medical Incorporated

People needed

44

Starts

2007-02-01

Expected to finish

2013-08-01

Last updated by the study team

2021-02-01

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years, < 85 years, life expectancy > 3yrs.
• Documented history of GERD symptoms such as heartburn and/or regurgitation.
• On daily PPI treatment for at least 3-months.
• Responsive to PPI treatment.
• GERD symptoms, in absence of PPI therapy (minimum 10 days).
• Ambulatory Esophageal pH < 4 for ≥ 5% time or pH < 4 for ≥ 3% time in supine position.
• Patient is a surgical candidate.
• Patient is willing and able to cooperate with follow-up examinations.
• Patient has been informed of the study procedures and the treatment and has signed an informed consent form and provided authorization to use and disclose information for research purposes (HIPAA).

You may not qualify if…

• The procedure is an emergency procedure.
• Patient is currently being treated with another investigational drug or investigational device.
• Patient has had prior gastric or esophageal surgery.
• Patient has had any previous endoscopic intervention for GERD
• Patient has suspected or confirmed esophageal or gastric cancer.
• Patient has any size paraesophageal hiatal hernia or sliding hiatal hernia ≥3cm. (Investigator to identify and record type of hiatal hernia at the time of assessment (i.e. para-esophageal, sliding)).
• Patient's esophageal motility is less than 35 mmHg peristaltic amplitude on wet swallows or > 30% failed (non-propulsive) peristaltic sequences.
• Patient has esophagitis - Grade B, C, D (LA Classification).
• Patient has Barretts Esophagus.
• Patient has BMI > 35.
• Patient has symptoms of dysphagia or indications of dysphagia from barium esophagram.
• Patient has Scleroderma and/or Achalasia.
• Patient has an esophageal stricture or gross esophageal anatomic abnormalities (obstructive lesions, etc.).
• Patient has an electrical implant or metallic, abdominal implant(s).
• Patient cannot understand trial requirements or is unable to comply with follow-up schedule.
• Patient is pregnant or nursing, or plans to become pregnant.
• Patient has a psychiatric disorder.

Where it is running

• University of Southern California, Keck School of Medicine — Los Angeles, California, United States
• Chapman Medical Center — Orange, California, United States
• Abbott Northwestern Hospital — Minneapolis, Minnesota, United States
• Policlinico San Donato — Milan, Italy
• Academisch Medisch Centrum (AMC) — Amsterdam, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.